TheEdgeResearch
Home / Stocks / HMPSF

The Hempshire Group, Inc. (HMPSF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.19 ▲ +0.00%
Market Cap
$15.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.12
52-Wk Range
0.1928-0.1928
CEO
Shawn Balaghi
Country
US
Currency
USD

The Hempshire Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Palm Springs, CA, US. The stock last traded at $0.19, up 0.00% on the session, giving a market capitalisation of $15.7M. On trailing twelve-month figures it carries a trailing P/E of -1.97, a net margin of -7300.9%. Its beta of 0.12 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-1.97
Price / Sales
176.05
Price / Book
12.83
EV / EBITDA
-2.49
Gross margin
28.8%
Operating margin
-2855.0%
Net margin
-7300.9%
Return on equity
—
Debt / equity
0.01
Current ratio
2.52
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
8
IPO date
2022-09-01
Headquarters
Palm Springs, CA, US
About The Hempshire Group, Inc.

The Hempshire Group, Inc. specializes in the full lifecycle of pharmaceutical-grade hemp and CBD products, encompassing their acquisition, production, branding, and refinement. Established in 2019, this company operates from its base in Palm Springs, California.

Comparable companies

The Hempshire Group, Inc. is most often compared with the following Healthcare names:

AMHVATHJFBFFTFGRAMFMGCLFNXTTFPKANFRAMMFRWBYFTGPHF
More research on HMPSF
HMPSF technical analysis HMPSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →